Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detectingBCR-ABL transcripts and kinase domain mutations and for expressing results.
Articolo
Data di Pubblicazione:
2006
Tipologia CRIS:
03A-Articolo su Rivista
Elenco autori:
Hughes T; Deininger M; Hochhaus A; Branford S; Radich J; Kaeda J; Baccarani
M; Cortes J; Cross NC; Druker BJ; Gabert J; Grimwade D; Hehlmann R; Kamel-Reid S;
Lipton JH; Longtine J; Martinelli G; Saglio G; Soverini S; Stock W; Goldman JM.
Link alla scheda completa:
Pubblicato in: